Form D · Biotechnology
Chickadee Biomedicines, Inc.
Boston, MA · CIK 0002138882
Offering snapshot reported Jun 25, 2026 · SEC filing
- Reported sold
- $150K Offering amount: $1M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 22, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 25, 2026 | Initial | $150,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-588534
Source: Form D, filed Jun 25, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mikael Goran Dolsten | Director, Executive, Promoter |
| Weining Lu | Director, Executive, Promoter |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
91 Oakmere Street
Boston, MA, 02132-5529
Phone: 617-302-2620
Boston, MA, 02132-5529
Phone: 617-302-2620